Donna Shoupe

No ORCID on file · 17 papers in corpus · active 2000-2023

Study types

  • article 10
  • book-chapter 5
  • review 2

Condition tags

  • endometriosis 2
  • mesh:D004715 1
  • mesh:D017699 1
book-chapter 2023
·doi:10.1007/978-3-031-14881-1_86
book-chapter 2022
·doi:10.1007/978-3-319-17002-2_86-2
article 2022
·doi:10.1016/j.fertnstert.2022.08.670
article 2019
·doi:10.1016/j.ygyno.2019.04.246
article 2019
·doi:10.1097/01.aog.0000558936.56738.7b

INTRODUCTION: The long-term benefits of ovarian conservation (OC) in young women have been well-established, however short-term outcomes remain relatively understudied. We examined utilization and outcomes of OC at the time of hysterectomy …

book-chapter 2017
·doi:10.1007/978-3-319-17798-4_86
article 2013
·doi:10.1097/aog.0b013e3182864350

OBJECTIVE: To report long-term mortality after oophorectomy or ovarian conservation at the time of hysterectomy in subgroups of women based on age at the time of surgery, use of estrogen therapy, presence of risk factors for coronary heart …

book-chapter 2010
·doi:10.1007/978-1-60327-864-5_11

The National Center for Health Statistics report that in 2004, of the 617,000 ­hysterectomies performed in the USA, 73% also involved the surgical removal of the ovaries. In the United States, by age 60, about 1/3 of women undergo a hystere…

article 2009
·doi:10.1097/aog.0b013e3181a11c64

OBJECTIVE: To report long-term health outcomes and mortality after oophorectomy or ovarian conservation. METHODS: We conducted a prospective, observational study of 29,380 women participants of the Nurses' Health Study who had a hysterectom…

review 2007
·doi:10.1097/gme.0b013e31803c56a4

OBJECTIVE: To review the risks and benefits of elective oophorectomy and to make a clinical recommendation for an appropriate age when benefits of this procedure outweigh the risks. DESIGN: The risks and benefits of oophorectomy as detailed…

book-chapter 2006
·doi:10.1007/978-1-59745-150-5_7

Depo-Provera® (depot medroxyprogesterone acetate [DMPA]) is an extremely effective contraceptive agent. Since its introduction into the market in the 1960s, DMPA has been used for a variety of gynecological conditions including endometriosi…

article 2005
·doi:10.1097/01.aog.0000186258.37099.a2

Parker, William H. MD; Broder, Michael S. MD, MPH; Berek, Jonathan S. MD, MMSc; Liu, Zhimei PhD; Shoupe, Donna MD; Farquhar, Jonathan S. MD Author Information

article 2005
·doi:10.1097/01.aog.0000190481.84868.7d

Parker, William H. MD; Broder, Michael S. MD, MPH; Liu, Zhimei PhD; Shoupe, Donna MD; Farquhar, Cindy MD; Berek, Jonathan S. MD, MMSc Author Information

article 2001
·doi:10.1016/s1074-3804(01)80086-4
article 2001
·doi:10.1016/s1074-3804(01)80088-8
article 2001
·doi:10.1016/s1074-3804(01)80089-x
review 2000
Hospital practice (1995) ·doi:10.3810/hp.2000.09.213

Even though hysterectomy remains an appealing solution for a number of nonmalignant gynecologic conditions, patients are often scheduled for surgery without proper evaluation or consideration of an alternative. For symptoms associated with …